A Arena

First name:
A
Last name:
Arena
Di Domenico, F., Tramutola, A., Barone, E., Lanzillotta, C., Defever, O., Arena, A., et al. (2019). Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biology, 23, 101162. https://doi.org/10.1016/j.redox.2019.101162
View
Sharma, N., Tramutola, A., Lanzillotta, C., Arena, A., Blarzino, C., Cassano, T., et al. (2019). Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. Neurobiology Of Disease, 125, 176-189. https://doi.org/10.1016/j.nbd.2019.02.003
View
Tramutola, A., Lanzillotta, C., Barone, E., Arena, A., Zuliani, I., Mosca, L., et al. Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome. Translational Neurodegeneration, 7, 28. https://doi.org/10.1186/s40035-018-0133-9 (Original work published 2018)
View
Di Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., et al. Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. Journal Of Alzheimer's Disease : Jad, 44(4), 1107-20. https://doi.org/10.3233/JAD-141254 (Original work published 2015)
View
Barone, E., Arena, A., Head, E., Butterfield, D. A., & Perluigi, M. (2018). Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism. Free Radical Biology & Medicine, 114, 84-93. https://doi.org/10.1016/j.freeradbiomed.2017.07.009
View
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., et al. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. Journal Of Alzheimer's Disease : Jad, 52(1), 359-371. https://doi.org/10.3233/JAD-151105 (Original work published 2016)
View
Barone, E., Di Domenico, F., Cassano, T., Arena, A., Tramutola, A., Lavecchia, M. A., et al. (2016). Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Free Radical Biology & Medicine, 91, 127-42. https://doi.org/10.1016/j.freeradbiomed.2015.12.012
View
Tramutola, A., Arena, A., Cini, C., Butterfield, D. A., & Barone, E. (2017). Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Expert Review Of Neurotherapeutics, 17(1), 59-75. https://doi.org/10.1080/14737175.2017.1246183
View
Tramutola, A., Di Domenico, F., Barone, E., Arena, A., Giorgi, A., di Francesco, L., et al. (2017). Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology. Antioxidants & Redox Signaling, 26(7), 280-298. https://doi.org/10.1089/ars.2016.6686 (Original work published 2017)
View